DSP-5336 for Blood Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to evaluate the absorption, metabolism, and excretion of DSP-5336 following a single oral administration of the study drug in patients with hematologic malignancies whose disease has progressed after available standard therapies.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Single oral administration of DSP-5336 to evaluate absorption, metabolism, and excretion
Follow-up
Participants are monitored for safety and effectiveness after treatment
Optional Continued Access
Participants may opt into continued access to DSP-5336
What Are the Treatments Tested in This Trial?
Interventions
- DSP-5336
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Part 2
Part 1
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sumitomo Pharma America, Inc.
Lead Sponsor
Jatin Shah
Sumitomo Pharma America, Inc.
Chief Medical Officer since 2024
MD from an unspecified institution
Tsutomu Nakagawa
Sumitomo Pharma America, Inc.
Chief Executive Officer since 2024
MBA from Waseda University
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.